Cover Image

Histone deacetylase inhibitors modulate KATP subunit transcription in HL-1 cardiomyocytes through effects on cholesterol homeostasis

Histone deacetylase inhibitors (HDIs) are under investigation for the treatment of a number of human health problems. HDIs have proven therapeutic value in refractory cases of cutaneous T-cell lymphoma,. Electrocardiographic ST segment morphological changes associated with HDIs were observed during...

Full description

Saved in:

Bibliographic Details
Main Authors:	Naheed eFatima (Author), Devin C Cohen (Author), Gauthaman eSukumar (Author), Tristan M Sissung (Author), James F Schooley (Author), Mark C Haigney (Author), William C Claycomb (Author), Rachel T Cox (Author), Clifton Lee Dalgard (Author), Susan E. Bates (Author), Thomas P Flagg (Author)
Format:	Book
Published:	Frontiers Media S.A., 2015-08-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

KATP channels and cardioprotection
by: Taskin Eylem, et al.
Published: (2024)

Role of Histone Deacetylase 6 and Histone Deacetylase 6 Inhibition in Colorectal Cancer
by: Ana Vuletić, et al.
Published: (2023)

Histone deacetylase inhibitors
by: Marzena Baran, et al.
Published: (2020)

Clinical Toxicities of Histone Deacetylase Inhibitors
by: Richard L. Piekarz, et al.
Published: (2010)

Histone acetylation and the role of histone deacetylases in normal cyclic endometrium
by: Palak Gujral, et al.
Published: (2020)

Medicinal chemistry of histone deacetylase inhibitors
by: Ružić Dušan, et al.
Published: (2021)

Zinc binding groups for histone deacetylase inhibitors
by: Lei Zhang, et al.
Published: (2018)

Role of histone deacetylases and their inhibitors in neurological diseases
by: Li-Ying Zhang, et al.
Published: (2024)

Overview of Histone Deacetylase Inhibitors in Haematological Malignancies
by: H. Miles Prince, et al.
Published: (2010)

Dual Inhibitors Targeting DNA and Histone Deacetylases
by: Chen Chen, et al.
Published: (2020)

Histone Deacetylase (HDAC) Inhibitors for the Treatment of Schistosomiasis
by: Ehab Ghazy, et al.
Published: (2022)

Advanced Progress of Histone Deacetylases in Rheumatic Diseases
by: Liu XM, et al.
Published: (2024)

The effects of the Histone Deacetylase (HDAC) Inhibitor 4-Phenylbutyrate on gap junction conductance and permeability
by: Joshua eKaufman, et al.
Published: (2013)

Histone deacetylase inhibition reduces cardiac Connexin43 expression and gap junction communication
by: Qin eXu, et al.
Published: (2013)

Carbocisteine Improves Histone Deacetylase 2 Deacetylation Activity via Regulating Sumoylation of Histone Deacetylase 2 in Human Tracheobronchial Epithelial Cells
by: Yun Song, et al.
Published: (2019)

The potential for histone deacetylase (HDAC) inhibitors as cestocidal drugs.
by: Hugo Rolando Vaca, et al.
Published: (2021)

Analysis of the interactome of Schistosoma mansoni histone deacetylase 8.
by: Stéphanie Caby, et al.
Published: (2017)

Natural Products Impacting DNA Methyltransferases and Histone Deacetylases
by: Sergi Herve Akone, et al.
Published: (2020)

HDACiDB: a database for histone deacetylase inhibitors
by: Murugan K, et al.
Published: (2015)

Targeting histone deacetylases for cancer therapy: Trends and challenges
by: Tao Liang, et al.
Published: (2023)

The Role and Mechanism of Histone Deacetylases in Acute Kidney Injury
by: Xun Zhou, et al.
Published: (2021)

Tetrahydroisoquinolines as novel histone deacetylase inhibitors for treatment of cancer
by: Danqi Chen, et al.
Published: (2016)

Research Progress on the Mechanism of Histone Deacetylases in Ferroptosis of Glioma
by: Meng Ma, et al.
Published: (2024)

Targeting Histone Deacetylases: Opportunities for Cancer Treatment and Chemoprevention
by: Dusan Ruzic, et al.
Published: (2022)

Histone Deacetylase Inhibitors in Cell Pluripotency, Differentiation, and Reprogramming
by: Androniki Kretsovali, et al.
Published: (2012)

Application of Histone Deacetylase Inhibitors in Renal Interstitial Fibrosis
by: Ling Nie, et al.
Published: (2020)

Structure-Based Identification of Novel Histone Deacetylase 4 (HDAC4) Inhibitors
by: Rupesh Agarwal, et al.
Published: (2024)

Mechanistic Insights into Binding of Ligands with Thiazolidinedione Warhead to Human Histone Deacetylase 4
by: Markus Schweipert, et al.
Published: (2021)

Repurposed drugs as histone deacetylase 8 inhibitors: Implications in cancer and neuropathological conditions
by: Mohammed Alrouji, et al.
Published: (2024)

The role of histone deacetylases in human gastrointestinal and associated glands cancer
by: Masumeh Sanaei, et al.
Published: (2019)

Synthesis and Crystal Structure Analysis of Histone Deacetylase Inhibitor Chidamide
by: Bo Han, et al.
Published: (2023)

Histone deacetylase inhibitors induce apoptosis in human eosinophils and neutrophils
by: Adcock Ian M, et al.
Published: (2010)

Discovery of potent histone deacetylase inhibitors with modified phenanthridine caps
by: Wenli Fan, et al.
Published: (2021)

Unveiling the role of histone deacetylases in neurological diseases: focus on epilepsy
by: Dan-Feng Cao, et al.
Published: (2024)

Histone Deacetylases Inhibitors in Neurodegenerative Diseases, Neuroprotection and Neuronal Differentiation
by: Surabhi Shukla, et al.
Published: (2020)

Clinical use and applications of histone deacetylase inhibitors in multiple myeloma
by: Tandon N, et al.
Published: (2016)

Mechanistic Sequence of Histone Deacetylase Inhibitors and Radiation Treatment: An Overview
by: Elsie Neo Seane, et al.
Published: (2024)

Photocaged Histone Deacetylase Inhibitors as Prodrugs in Targeted Cancer Therapy
by: Fabian B. Kraft, et al.
Published: (2023)

Medicinal chemistry advances in targeting class I histone deacetylases
by: Diaaeldin I. Abdallah, et al.
Published: (2023)

Targeting Histone Deacetylases 6 in Dual-Target Therapy of Cancer
by: Milan Beljkas, et al.
Published: (2023)